Asian ethnicity and breast cancer subtypes: A study from the California Cancer Registry

Breast Cancer Research and Treatment

Volumn 127, Issue 2, 2011, Pages 471-478

  Telli, Melinda L ^a   Chang, Ellen T ^a,b   Kurian, Allison W ^a   Keegan, Theresa H M ^a,b   McClure, Laura A ^b   Lichtensztajn, Daphne ^b   Ford, James M ^a   Gomez, Scarlett L ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CANCER PREVENTION INSTITUTE OF CALIFORNIA   (United States)

Author keywords

Asian; Breast cancer subtypes; Ethnicity; HER2 positive breast cancer; Hormone receptor positive breast cancer; Triple negative breast cancer

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR;

AGE DISTRIBUTION; ARTICLE; ASIAN; BREAST CANCER; CANCER INCIDENCE; CANCER INVASION; CANCER REGISTRY; CANCER STAGING; CHINESE; CONTROLLED STUDY; DEMOGRAPHY; ETHNICITY; FEMALE; FILIPINO; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; JAPANESE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; RACE DIFFERENCE; RISK FACTOR; SOCIAL STATUS; UNITED STATES;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; CALIFORNIA; FEMALE; HUMANS; MIDDLE AGED; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; REGISTRIES;

EID: 79958217700     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-1173-8     Document Type: Article

References (46)

1. CM Perou T Sorlie MB Eisen, et al. 2000 Molecular portraits of human breast tumours Nature 406 747 752 10963602 10.1038/35021093 1:CAS:528: DC%2BD3cXmt1CnsLw%3D
2. T Sorlie R Tibshirani J Parker, et al. 2003 Repeated observation of breast tumor subtypes in independent gene expression data sets Proc Natl Acad Sci U S A 100 8418 8423 12829800 10.1073/pnas.0932692100 1:CAS:528: DC%2BD3sXlsFGntLk%3D (Pubitemid 36842560)
3. LA Carey CM Perou CA Livasy, et al. 2006 Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study JAMA 295 2492 2502 16757721 10.1001/jama.295.21.2492 1:CAS:528:DC%2BD28XlsV2rtLw%3D (Pubitemid 43854964)
4. R Dent M Trudeau KI Pritchard, et al. 2007 Triple-negative breast cancer: clinical features and patterns of recurrence Clin Cancer Res 13 4429 4434 17671126 10.1158/1078-0432.CCR-06-3045 (Pubitemid 47219710)
5. EA Rakha DA El-Rehim C Paish, et al. 2006 Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance Eur J Cancer 42 3149 3156 17055256 10.1016/j.ejca.2006.08.015 1:CAS:528:DC%2BD28Xht12rtrzK (Pubitemid 44854512)
6. DJ Slamon GM Clark SG Wong, et al. 1987 Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene Science 235 177 182 3798106 10.1126/science.3798106 1:CAS:528:DyaL2sXhtVSht7s%3D (Pubitemid 17231334)
7. MC Cheang D Voduc C Bajdik, et al. 2008 Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype Clin Cancer Res 14 1368 1376 18316557 10.1158/1078-0432.CCR-07-1658 1:CAS:528:DC%2BD1cXislSrs7o%3D (Pubitemid 351413917)
8. TO Nielsen FD Hsu K Jensen, et al. 2004 Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma Clin Cancer Res 10 5367 5374 15328174 10.1158/1078-0432.CCR-04-0220 1:CAS:528:DC%2BD2cXmvFSlt7k%3D (Pubitemid 39100473)
9. M Tischkowitz JS Brunet LR Begin, et al. 2007 Use of immunohistochemical markers can refine prognosis in triple negative breast cancer BMC Cancer 7 134 17650314 10.1186/1471-2407-7-134 (Pubitemid 47272190)
10. D Huo F Ikpatt A Khramtsov, et al. 2009 Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer J Clin Oncol 27 4515 4521 19704069 10.1200/JCO.2008.19.6873 1:CAS:528:DC%2BD1MXhtlCns77P
11. KR Bauer M Brown RD Cress, et al. 2007 Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California Cancer Registry Cancer 109 1721 1728 17387718 10.1002/cncr.22618 (Pubitemid 46668532)
12. MJ Lund KF Trivers PL Porter, et al. 2009 Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA Breast Cancer Res Treat 113 357 370 18324472 10.1007/s10549-008-9926-3
13. A Liede SA Narod 2002 Hereditary breast and ovarian cancer in Asia: genetic epidemiology of BRCA1 and BRCA2 Hum Mutat 20 413 424 12442265 10.1002/humu.10154 1:CAS:528:DC%2BD38Xps1yjs7w%3D (Pubitemid 35453558)
14. CH Yip 2009 Breast cancer in Asia Methods Mol Biol 471 51 64 19109774 10.1007/978-1-59745-416-2-3
15. A Seow SW Duffy MA McGee, et al. 1996 Breast cancer in Singapore: trends in incidence 1968-1992 Int J Epidemiol 25 40 45 8666502 10.1093/ije/25.1.40 1:STN:280:DyaK283jslWnsA%3D%3D (Pubitemid 26060268)
16. TH Keegan SL Gomez CA Clarke, et al. 2007 Recent trends in breast cancer incidence among 6 Asian groups in the Greater Bay Area of Northern California Int J Cancer 120 1324 1329 17163416 10.1002/ijc.22432 1:CAS:528: DC%2BD2sXhvVOju7Y%3D
17. L Yang DM Parkin J Ferlay, et al. 2005 Estimates of cancer incidence in China for 2000, projections for 2005 Cancer Epidemiol Biomarkers Prev 14 243 250 15668501 10.1158/1055-9965.EPI-04-0680 (Pubitemid 40478554)
18. L Yang DM Parkin L Li, et al. 2003 Time trends in cancer mortality in China: 1987-1999 Int J Cancer 106 771 783 12866039 10.1002/ijc.11300 1:CAS:528:DC%2BD3sXms1Wjsrg%3D (Pubitemid 37006314)
19. L Yang DM Parkin LD Li, et al. 2004 Estimation and projection of the national profile of cancer mortality in China: 1991-2005 Br J Cancer 90 2157 2166 15150609 1:STN:280:DC%2BD2c3msVOqtw%3D%3D (Pubitemid 38869723)
20. BH Son BS Kwak JK Kim, et al. 2006 Changing patterns in the clinical characteristics of Korean patients with breast cancer during the last 15 years Arch Surg 141 155 160 16490892 10.1001/archsurg.141.2.155 (Pubitemid 43276565)
21. BA Miller KC Chu BF Hankey, et al. 2008 Cancer incidence and mortality patterns among specific Asian and Pacific Islander populations in the U.S Cancer Causes Control 19 227 256 18066673 10.1007/s10552-007-9088-3
22. CI Li KE Malone JR Daling 2003 Differences in breast cancer stage, treatment, and survival by race and ethnicity Arch Intern Med 163 49 56 12523916 10.1001/archinte.163.1.49 (Pubitemid 36091600)
23. CI Li KE Malone JR Daling 2002 Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older Cancer Epidemiol Biomarkers Prev 11 601 607 12101106 (Pubitemid 34760817)
24. ML Kwan LH Kushi E Weltzien, et al. 2009 Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors Breast Cancer Res 11 R31 19463150 10.1186/bcr2261
25. CA Parise KR Bauer MM Brown, et al. 2009 Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004 Breast J 15 6 593 602 19764994 10.1111/j.1524-4741.2009.00822.x (E pub 9/22/2009)
26. SL Gomez GM Le DW West, et al. 2003 Hospital policy and practice regarding the collection of data on race, ethnicity, and birthplace Am J Public Health 93 1685 1688 14534222 10.2105/AJPH.93.10.1685 (Pubitemid 38477635)
27. K Yost C Perkins R Cohen, et al. 2001 Socioeconomic status and breast cancer incidence in California for different race/ethnic groups Cancer Causes Control 12 703 711 11562110 10.1023/A:1011240019516 1:STN:280: DC%2BD3MrhsVantw%3D%3D (Pubitemid 32803497)
28. G Block GM Matanoski RS Seltser 1983 A method for estimating year of birth using social security number Am J Epidemiol 118 377 395 6613981 1:STN:280:DyaL3szgsFOhsA%3D%3D (Pubitemid 13050716)
29. H Shimizu RK Ross L Bernstein, et al. 1991 Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County Br J Cancer 63 963 966 2069852 10.1038/bjc.1991.210 1:STN:280:DyaK3M3pvFCqtw%3D%3D
30. SL Gomez SL Glaser JL Kelsey, et al. 2004 Bias in completeness of birthplace data for Asian groups in a population-based cancer registry (United States) Cancer Causes Control 15 243 253 15090719 10.1023/B:CACO.0000024244. 91775.64 (Pubitemid 38988033)
31. California Cancer Reporting System Standards, Vol. 1, Cancer Reporting in California Abstracting and Coding Procedures for Hospitals, Eighth Edition, Revised May, 2008: V.7.5 AJCC Stage Group. http://www.ccrcal.org/Vol-1-May-2008- html/Vol-1-08.htm
32. California Cancer Reporting System Standards, Vol. 1, Cancer Reporting in California Abstracting and Coding Procedures for Hospitals, Eighth Edition, Revised May, 2008: V.3.5.8 Bloom-Richardson Grade for Breast Cancer. http://www.ccrcal.org/Vol-1-May-2008-html/Vol-1-08.htm
33. Office of Statewide Health Planning and Development (OSHPD) Annual Utilization Report of Hospitals (2001). http://www.oshpd.cahwnet.gov
34. California Cancer Reporting System Standards, Vol. 1, Cancer Reporting in California Abstracting and Coding Procedures for Hospitals, Eighth Edition, Revised May, 2008. http://www.ccrcal.org/Vol-1-May-2008-html/Vol-1-08.htm
35. California Cancer Reporting System Standards, Vol. 1, Cancer Reporting in California Abstracting and Coding Procedures for Hospitals, Eighth Edition, Revised May, 2008: V.6.4 Tumor Marker California-1. http://www.ccrcal.org/Vol-1- May-2008-html/Vol-1-08.htm
36. H Ma Y Wang J Sullivan-Halley, et al. 2009 Breast cancer receptor status: do results from a centralized pathology laboratory agree with SEER registry reports? Cancer Epidemiol Biomarkers Prev 18 2214 2220 19661080 10.1158/1055-9965.EPI-09-0301 1:CAS:528:DC%2BD1MXps1eqtL8%3D
37. Daly MB, Axilbund JE, Bryant E, et al (2010) NCCN clinical practice guidelines in oncology. Genetic/familial high-risk assessment: breast and ovarian, v. 1. 2010, p 18. Available at http://www.nccn.org
38. WD Foulkes IM Stefansson PO Chappuis, et al. 2003 Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer J Natl Cancer Inst 95 1482 1485 14519755 1:CAS:528:DC%2BD3sXnvVCjtrk%3D (Pubitemid 37279334)
39. SR Lakhani MJ Van De Vijver J Jacquemier, et al. 2002 The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2 J Clin Oncol 20 2310 2318 11981002 10.1200/JCO.2002.09.023 1:CAS:528:DC%2BD38XktVKrs7o%3D (Pubitemid 34441658)
40. OI Olopade T Grushko 2001 Gene-expression profiles in hereditary breast cancer N Engl J Med 344 2028 2029 11430337 10.1056/NEJM200106283442613 1:STN:280:DC%2BD3MzntlGrtw%3D%3D (Pubitemid 32568161)
41. TA Grushko MA Blackwood PL Schumm, et al. 2002 Molecular-cytogenetic analysis of HER-2/neu gene in BRCA1-associated breast cancers Cancer Res 62 1481 1488 11888924 1:CAS:528:DC%2BD38Xit1Khu78%3D (Pubitemid 34407811)
42. W Han SW Kim IA Park, et al. 2004 Young age: an independent risk factor for disease-free survival in women with operable breast cancer BMC Cancer 4 82 15546499 10.1186/1471-2407-4-82 (Pubitemid 40180272)
43. RG Ziegler RN Hoover MC Pike, et al. 1993 Migration patterns and breast cancer risk in Asian-American women J Natl Cancer Inst 85 1819 1827 8230262 10.1093/jnci/85.22.1819 1:STN:280:DyaK2c%2FkslWgsQ%3D%3D (Pubitemid 23333614)
44. RW Carlson DC Allred BO Anderson, et al. 2009 NCCN clinical practice guideline: breast cancer J Natl Compr Canc Netw 7 122 192 19200416 1:CAS:528:DC%2BD1MXjs1Oktbg%3D
45. AW Kurian RN Thompson AF Gaw, et al. 2007 A cost-effectiveness analysis of adjuvant trastuzumab regimens in early HER2/neu-positive breast cancer J Clin Oncol 25 634 641 17308268 10.1200/JCO.2006.06.3081 1:CAS:528: DC%2BD2sXjt1Kgu7w%3D (Pubitemid 350002917)
46. N Krieger 1992 Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology Am J Public Health 82 703 710 1566949 10.2105/AJPH.82.5.703 1:STN:280:DyaK383jtV2ksg%3D%3D